Akshya Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akshya Gupta has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth A. Sadowski
Department of Radiology, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wis
5 shared publications - Priyanka Jha
Stanford University, Stanford, USA
5 shared publications - Katherine E. Maturen
Departments of Radiology and Obstetrics and Gynecology, University of Michigan, Ann Arbor, Mich
4 shared publications - Krupa K. Patel-Lippmann
Department of Radiology, Vanderbilt Health, Nashville, Tenn
4 shared publications - Lisa Barroilhet
University of Wisconsin–Madison 6 Madison, WI
4 shared publications - Aya Kamaya
Department of Radiology, Stanford Medical Center, Stanford, Calif
3 shared publications
Latest Publications
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e252310
Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis
Solid components and multilocularity were frequently found among benign lesions scored as Ovarian-Adnexal Reporting and Data System (O-RADS) 4 or 5, with cystadenomas and cystadenofibromas being the most common benign lesions.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e252310
Benign Lesions Scored as O-RADS US v2022 4 and 5 Categories: Prevalence and Morphologic Analysis
Solid components and multilocularity were frequently found among benign lesions scored as Ovarian-Adnexal Reporting and Data System (O-RADS) 4 or 5, with cystadenomas and cystadenofibromas being the most common benign lesions.
- 3 March 2026
- Published by Springer Nature in Abdominal Radiology
Working in concert: radiology, pathology, and gynecologic oncology applications of the 2023 FIGO updates in endometrial cancer staging
The 2023 FIGO staging update for endometrial cancer moves beyond anatomy to integrate histology and molecular classification. This review outlines the new framework, illustrates its application through radiologic-pathologic case vignettes, and highlights how multidisciplinary input guides staging and therapy. Major revisions include separate substages for aggressive histologies, depth-based divisions incorporating LVSI, and molecularly driven categories such as POLE-abnormal and p53-abnormal tumors. Although these refinements sharpen prognostic accuracy, unequal access to advanced testing and interpretive variability remain obstacles to uniform implementation.
- 3 March 2026
- Published by Springer Nature in Abdominal Radiology
Working in concert: radiology, pathology, and gynecologic oncology applications of the 2023 FIGO updates in endometrial cancer staging
The 2023 FIGO staging update for endometrial cancer moves beyond anatomy to integrate histology and molecular classification. This review outlines the new framework, illustrates its application through radiologic-pathologic case vignettes, and highlights how multidisciplinary input guides staging and therapy. Major revisions include separate substages for aggressive histologies, depth-based divisions incorporating LVSI, and molecularly driven categories such as POLE-abnormal and p53-abnormal tumors. Although these refinements sharpen prognostic accuracy, unequal access to advanced testing and interpretive variability remain obstacles to uniform implementation.
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240044
The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate
Among ovarian and adnexal lesions surgically removed before 2015, a large proportion were retrospectively assessed as Ovarian-Adnexal Imaging Reporting and Data System US 2, which may have allowed for more conservative management in these patients.
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240044
The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate
Among ovarian and adnexal lesions surgically removed before 2015, a large proportion were retrospectively assessed as Ovarian-Adnexal Imaging Reporting and Data System US 2, which may have allowed for more conservative management in these patients.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e233332
The Roles of Ovarian-Adnexal Reporting and Data System US and Ovarian-Adnexal Reporting and Data System MRI in the Evaluation of Adnexal Lesions
Ovarian-Adnexal Reporting and Data System US and MRI provide evidence-based lexicons and risk assessment systems that can accurately diagnose most adnexal lesions as benign and effectively risk stratify those that are suspicious for malignancy.
- 1 August 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 312 (2) , e233332
The Roles of Ovarian-Adnexal Reporting and Data System US and Ovarian-Adnexal Reporting and Data System MRI in the Evaluation of Adnexal Lesions
Ovarian-Adnexal Reporting and Data System US and MRI provide evidence-based lexicons and risk assessment systems that can accurately diagnose most adnexal lesions as benign and effectively risk stratify those that are suspicious for malignancy.
- 1 June 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (5) , 223281
Adnexal Lesion Imaging: Past, Present, and Future
Currently, imaging is part of the standard of care for patients with adnexal lesions prior to definitive management. Imaging can identify a physiologic finding or classic benign lesion that can be followed up conservatively. When one of these entities is not present, imaging is used to determine the probability of ovarian cancer prior to surgical consultation. Since the inclusion of imaging in the evaluation of adnexal lesions in the 1970s, the rate of surgery for benign lesions has decreased. More recently, data-driven Ovarian-Adnexal Reporting and Data System (O-RADS) scoring systems for US and MRI with standardized lexicons have been developed to allow for assignment of a cancer risk score, with the goal of further decreasing unnecessary interventions while expediting the care of patients with ovarian cancer. US is used as the initial modality for the assessment of adnexal lesions, while MRI is used when there is a clinical need for increased specificity and positive predictive value for the diagnosis of cancer. This article will review how the treatment of adnexal lesions has changed due to imaging over the decades; the current data supporting the use of US, CT, and MRI to determine the likelihood of cancer; and future directions of adnexal imaging for the early detection of ovarian cancer.
- 1 June 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (5) , 223281
Adnexal Lesion Imaging: Past, Present, and Future
Currently, imaging is part of the standard of care for patients with adnexal lesions prior to definitive management. Imaging can identify a physiologic finding or classic benign lesion that can be followed up conservatively. When one of these entities is not present, imaging is used to determine the probability of ovarian cancer prior to surgical consultation. Since the inclusion of imaging in the evaluation of adnexal lesions in the 1970s, the rate of surgery for benign lesions has decreased. More recently, data-driven Ovarian-Adnexal Reporting and Data System (O-RADS) scoring systems for US and MRI with standardized lexicons have been developed to allow for assignment of a cancer risk score, with the goal of further decreasing unnecessary interventions while expediting the care of patients with ovarian cancer. US is used as the initial modality for the assessment of adnexal lesions, while MRI is used when there is a clinical need for increased specificity and positive predictive value for the diagnosis of cancer. This article will review how the treatment of adnexal lesions has changed due to imaging over the decades; the current data supporting the use of US, CT, and MRI to determine the likelihood of cancer; and future directions of adnexal imaging for the early detection of ovarian cancer.
- 31 January 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (5) , 1724-1739
Thyroid cancer in pregnancy: diagnosis, management, and treatment
The evaluation and management of cancer during pregnancy requires special care to assure the health and safety of both the mother and fetus. The diagnosis and treatment of thyroid cancer in the non-pregnant patient often involves radioactive iodine exposure. However, radioactive iodine is contraindicated in pregnancy and surgical interventions pose risks to both the mother and fetus. Thus, the management of thyroid cancer during pregnancy is a unique clinical challenge. In this review, we discuss the imaging of thyroid nodules during pregnancy, including the role of CT, MRI, and nuclear Imaging, as well as that of Ultrasound and FNA. The staging and prognosis are discussed along with the management, treatment, and surveillance of thyroid cancer in pregnancy. Finally, the risks to the fetus through treatment are examined. Case examples are provided with an emphasis on the appropriate direction of care from a radiologist’s perspective.
- 31 January 2023
- Published by Springer Nature in Abdominal Radiology
- Vol. 48 (5) , 1724-1739
Thyroid cancer in pregnancy: diagnosis, management, and treatment
The evaluation and management of cancer during pregnancy requires special care to assure the health and safety of both the mother and fetus. The diagnosis and treatment of thyroid cancer in the non-pregnant patient often involves radioactive iodine exposure. However, radioactive iodine is contraindicated in pregnancy and surgical interventions pose risks to both the mother and fetus. Thus, the management of thyroid cancer during pregnancy is a unique clinical challenge. In this review, we discuss the imaging of thyroid nodules during pregnancy, including the role of CT, MRI, and nuclear Imaging, as well as that of Ultrasound and FNA. The staging and prognosis are discussed along with the management, treatment, and surveillance of thyroid cancer in pregnancy. Finally, the risks to the fetus through treatment are examined. Case examples are provided with an emphasis on the appropriate direction of care from a radiologist’s perspective.
- Open Access
Prostate Cancer—PET Imaging Update
Prostate cancer is the most common non-dermatologic cancer in men, and one of the leading causes of cancer-related mortality. The incidence of prostate cancer increases precipitously after the age of 65 and demonstrates variable aggressiveness, depending on its grade and stage at diagnosis. Despite recent advancements in prostate cancer treatment, recurrence is seen in 25% of patients. Advancements in prostate cancer Positron Emission Tomography (PET) molecular imaging and recent United States Food and Drug Administration (FDA) approvals have led to several new options for evaluating prostate cancer. This manuscript will review the commonly used molecular imaging agents, with an emphasis on Fluorine-18 fluciclovine (Axumin) and PSMA-ligand agents, including their protocols, imaging interpretation, and pitfalls.
Open AccessProstate Cancer—PET Imaging Update
Prostate cancer is the most common non-dermatologic cancer in men, and one of the leading causes of cancer-related mortality. The incidence of prostate cancer increases precipitously after the age of 65 and demonstrates variable aggressiveness, depending on its grade and stage at diagnosis. Despite recent advancements in prostate cancer treatment, recurrence is seen in 25% of patients. Advancements in prostate cancer Positron Emission Tomography (PET) molecular imaging and recent United States Food and Drug Administration (FDA) approvals have led to several new options for evaluating prostate cancer. This manuscript will review the commonly used molecular imaging agents, with an emphasis on Fluorine-18 fluciclovine (Axumin) and PSMA-ligand agents, including their protocols, imaging interpretation, and pitfalls.
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 603-610
Ovarian Cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at US
In women at average risk for ovarian cancer, assessing isolated adnexal lesions as classic- versus nonclassic-appearing at US had high sensitivity and specificity, similar to published risk stratif... Background Several US risk stratification schemas for assessing adnexal lesions exist. These multiple-subcategory systems may be more multifaceted than necessary for isolated adnexal lesions in ave...
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 603-610
Ovarian Cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at US
In women at average risk for ovarian cancer, assessing isolated adnexal lesions as classic- versus nonclassic-appearing at US had high sensitivity and specificity, similar to published risk stratif... Background Several US risk stratification schemas for assessing adnexal lesions exist. These multiple-subcategory systems may be more multifaceted than necessary for isolated adnexal lesions in ave...
- 1 May 2022
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 218 (5) , 844
Editorial Comment: Multiinstitutional Validation of Liver Surface Nodularity Score
This Editorial Comment discusses the following AJR article: Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C.
- 1 May 2022
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 218 (5) , 844
Editorial Comment: Multiinstitutional Validation of Liver Surface Nodularity Score
This Editorial Comment discusses the following AJR article: Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients with Hepatitis C.
- 24 February 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (6) , 679-686
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
- 24 February 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (6) , 679-686
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis